Article Access Statistics | | Viewed | 606 | | Printed | 18 | | Emailed | 0 | | PDF Downloaded | 17 | | Comments | [Add] | |
|

 Click on image for details.
|
|
|
REVIEW ARTICLE |
|
|
|
Year : 2022 | Volume
: 70
| Issue : 2 | Page : 491-503 |
Complex Regional Pain Syndrome after Carpal Tunnel Syndrome Surgery: A Systematic Review
Luis Henrique A. Sousa1, Caroline de O. Costa2, Eduardo M Novak2, Giana S Giostri2
1 Division of Neurosurgery, Cajuru University Hospital, Curitiba, Brazil Cajuru University Hospital, Curitiba, Brazil 2 Division of Hand Surgery, Cajuru University Hospital, Curitiba, Brazil Cajuru University Hospital, Curitiba, Brazil
Date of Submission | 22-Aug-2020 |
Date of Decision | 21-Sep-2020 |
Date of Acceptance | 20-Dec-2020 |
Date of Web Publication | 3-May-2022 |
Correspondence Address: Dr. Luis Henrique A. Sousa Albuquerque Sousa, Adress: Rua Capote Valente, 1300, zip code: 05409003 Brazil
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0028-3886.344616
Background: Carpal tunnel syndrome (CTS) is the most common peripheral nerve entrapment. One of the most devastating complications is complex regional pain syndrome. Objectivities: The aim of this study was to systematically analyze available evidence about complex regional pain syndrome after carpal tunnel syndrome surgery (CTSS), its risks, associated factors, and treatments. Material and Methods: Research conducted from 1962 through December 31, 2018, in the following databases: PubMed, Web of Science, Cochrane Database of Systematic Reviews, and Cochrane Central Register of Controlled Trials. The quality assessment of the methodology followed the definitions by the Oxford Centre for Evidence-Based Medicine 2011 Levels of Evidence. The GRADE system (Grades of Recommendation, Assessment, Development, and Evaluation) was applied to evaluate the efficacy of the stellate ganglion block, one of the most cited and recurrent treatments. Results: Of the 246 studies retrieved, 44 articles were included. Concerning patients' gender, we identified a ratio of 5 females: 3 males. The mean age for women was 57.79, a standard deviation of 14.96, and for men 60.75, a standard deviation of 9.4. Considering the total of primary publications of CTSS outcomes, the accumulated incidence reached the maximum of 0.15 CRPS after CTSS patients/CTSS patients. The known risk factors for CRPS after CTSS: female gender, from the fifth decade of life, tourniquet time, immobilization and surgery on dominant hand. Conclusion: CRPS affects 2-5% of people undergoing CTSS. Its diagnosis is still a challenge and its risk factors are unclear, although it seems more likely to affect women, in the dominant hand. The most used treatments include physiotherapy and stellate ganglion block. Most patients show improvement of symptoms within one year. Further clinical trials comparing treatment modalities are required.
Keywords: Carpal tunnel syndrome, carpal tunnel syndrome surgery, complex regional pain syndrome, complications Key message: CRPS after CTSS is more likely to affect women, older than 40 years of age, in the dominant hand. The most used treatments include physiotherapy and stellate ganglion block. Most patients improve the symptoms within one year.
How to cite this article: A. Sousa LH, O. Costa Cd, Novak EM, Giostri GS. Complex Regional Pain Syndrome after Carpal Tunnel Syndrome Surgery: A Systematic Review. Neurol India 2022;70:491-503 |
How to cite this URL: A. Sousa LH, O. Costa Cd, Novak EM, Giostri GS. Complex Regional Pain Syndrome after Carpal Tunnel Syndrome Surgery: A Systematic Review. Neurol India [serial online] 2022 [cited 2022 Jul 3];70:491-503. Available from: https://www.neurologyindia.com/text.asp?2022/70/2/491/344616 |
Carpal tunnel syndrome (CTS) is the most common peripheral nerve entrapment at global level,[1],[2] with a prevalence among the general population ranging from 4[3] to 7%.[4],[5] Surgical treatment presents complication rates lower than 3%,[6] including complex regional pain syndrome (CRPS),[7],[8] a devastating chronic pain syndrome with difficult and not well-known prevention and management. Despite low complication rates, the high incidence of CTS makes CRPS common in clinical practice.
This paper aims to analyze available evidence about the complex regional pain syndrome after carpal tunnel syndrome surgery (CTSS), its risks, associated factors, and treatments.
» Material and Methods | |  |
A systematic literature review was performed and registered at Prospero (International prospective register of systematic reviews), under number CRD42019122840.
The two main authors searched the articles in PubMed, Web of Science, Cochrane Database of Systematic Reviews and Cochrane Central Register of Controlled Trials, by applying the following MeSH terms and subheadings in all fields: “Carpal Tunnel Syndrome” OR “Carpal Tunnel Syndrome Surgery” associated with “Complex Regional Pain Syndromes” OR “Causalgia” OR “Reflex Sympathetic Dystrophy”. The covered search period was from 1962 to December 31st, 2018.
Inclusion criteria
Authors followed the PICOT approach, specifying Population as patients that developed CRPS after CTSS; Intervention as any form of CRPS treatment; Primary outcome as the improvement of CRPS symptoms, measured in any scale. Secondary outcomes included any scale of measured quality of life and complications related to CRPS treatment. Publications with missing or incomplete description of outcomes were also accepted. The study designs accepted included literature reviews, clinical trials, case-control studies, cohort studies, case reports, and specialist reports. Regarding Time, any length of follow-up was accepted. Additionally, only articles published in English, Portuguese, and Spanish, with available abstracts were included. A secondary review was performed using the reference list of the eligible articles. Some other articles were included aiming to improve the discussion.
Exclusion criteria
All titles and abstracts were evaluated by main authors and excluded by consensus if CRPS symptoms reported were caused by other comorbidities. Articles that reported CRPS cases in which patients developed CTS after trauma or those that received conservative treatment were also excluded. Additionally, articles that did not meet the main purpose of this manuscript were excluded.
The quality assessment of the methodology, performed by the two main authors, followed the definitions by Oxford Centre for Evidence-Based Medicine 2011 Levels of Evidence (OCEBM L).[9],[10],[11] Other authors were consulted when consensus regarding the inclusion of articles was not reached. It has been recurrently described that stellate ganglion block, used in the treatment for CRPS after CTSS, represents an important outcome, whose quality was assessed by applying the GRADE system (Grades of Recommendation, Assessment, Development, and Evaluation).[12] Meta-analysis was not performed due to paucity of complete data and quantitative analysis was used to summarize previous results.
» Results | |  |
According to previous search strategy, a total of 246 citations, published from 1962 to 2018, were collected. After removal of duplicates (43), articles in other languages (28) and without abstract (22), 153 articles remained. Some articles were excluded for their out-of-date nature and for not being available in the online journal repository[7],[13],[14],[15] (4), for being categorized as conference papers (2) and for not presenting published data of trial results[16] (1). Seventy-four additional articles were excluded after title and abstract evaluation, and 28 after full-text reading. The remaining 44 articles were considered suitable to be used in this review [Figure 1], namely 11 literature reviews[6],[17],[18],[19],[20],[21],[22],[23],[24],[25],[26] (6 systematic), 10 randomized controlled trials (RCT),[27],[28],[29],[30],[31],[32],[33],[34],[35],[36] 9 cohort studies[37],[38],[39],[40],[41],[42],[43],[44],[45] and 14 case reports/case series.[8],[46],[47],[48],[49],[50],[51],[52],[53],[54],[55],[56],[57],[58]
The quality of evidence of the selected articles, provided by GRADE, ranged from level 1 to 5 (almost 30% with OCBM level of 4-5). Although several articles describe CTSS techniques and surgical procedures, few describe CRPS after CTSS condition [Table 1], [Table 2], [Table 3], [Table 4]. In fact, the lack of specific information limits the analysis of patient characterization and CRPS treatment in the present review. It has been identified that epidemiological information, such as age and gender, is missing in 50% of the articles (22 studies: 9 CR/CS, 4 Cohort, 9 RCT). Similarly, clinical information, such as comorbidities, symptoms and physical examination, is not reported in 20 studies (9CR/CS, 2 Cohort, 9RCT); specification and description of CRPS treatment are not provided in 13 studies (7 CR/CS, 4 Cohort, 6 RCT); and follow up information related to its length and related outcomes is not listed in 22 studies (9 CS/CR, 6 Cohort, 7 RCT). Considering the information available, only 61 patients were identified according to their gender, a ratio of 5 females: 3 males. Regarding the patients' age, the mean for women was 57.79, a standard deviation of 14.96. For men, the mean age was 60.75, a standard deviation of 9.4. | Table 1: Case series and case reports studies included in the review criteria and Author analysis of their limitations and level of evidence
Click here to view |
 | Table 2: Cohort studies included in the review criteria and Author analysis of their limitations and level of evidence
Click here to view |
 | Table 3: Randomized clinical trials studies included in the review criteria and author analysis of their limitations and level of evidence
Click here to view |
 | Table 4: Literature Reviews included in the review criteria and Author analysis of their limitations and level of evidence
Click here to view |
Considering the total number of primary publications on CTSS outcomes (24 studies: 8CS, 6 cohort, 10 RCT), the accumulated incidence reached the maximum of 0.15 CRPS after CTSS patients/CTSS patients [Figure 2]. | Figure 2: CRPS accumulative incidence described in follow up studies of CTSS outcomes per publication study year
Click here to view |
Seventeen articles reported treatments used for CRPS after CTSS; the most prevailing were stellate ganglion block (5 papers – 2 CS/CR, 2 Cohort, 1 RCT) and physiotherapy (6 papers – 1 CS/CR, 3 Cohort, 2 RCT). The overall efficacy grade for the CRPS treatment, measured in any scale for pain control and quality of life, is very low (1 RCT, 4 observational studies, limited due to indirectness and use of spare data).
Only 7 papers (2 LR, 3 Cohort, 1 CS/CR, 1 RCT) addressed risk factors for developing CRPS, and only 3 articles detailed risk factors for CRPS after CTSS, namely, tourniquet time (RCT), immobilization (CS/CR), female gender, surgery on dominant hand and age older than 42 years (Cohort). One cohort study suggested that Laser Doppler Image may identify patients with higher risk for developing CRPS again, even after being successfully treated. Fewer than one third of publications documented CRPS after CTSS as one of the major topics (7CR/CS, 4 Cohort, 1 RCT, 1 SR, 1 NR).
» Discussion | |  |
This is the first systematic review, to the best of our knowledge, addressing complex regional pain syndrome after CTSS. Although it is a well-described complication, publications on the syndrome are relatively new. The first case series was published in 1978,[8] while the first systematic review included cases 20 years later,[23]. There has been an increasing interest over the years addressing this complication, reflecting the number of publications and the quality of primary study design[23] [Figure 3], while the total number of publications for year about CTS have decreased.[60] | Figure 3: CRPS after CTSS patients described along years of medical publication of primary studies. Logarithmic scale (base 5)
Click here to view |
CRPS definition and diagnosis
CRPS is a clinical debilitating condition characterized by chronic pain, sensorial changes and vasomotor symptoms in the affected limb.[61],[62] The typical signs are burning and severe pain, edema, allodynia, differences in temperature and skin color and motor dysfunction, usually with joint stiffness.[24],[49],[55],[56],[61],[62],[63] The first symptoms of CRPS after CTSS may appear early in the recovery room, although most patients present symptoms 1 to 3 weeks after surgery.[24]
Full identification of CRPS has been challenging. For a long time, other names, such as reflex sympathetic dystrophy and causalgia, have described the syndrome. This inconsistency has caused a delay in identifying its risk factors, diagnostic criteria and treatment options.[61] Only in 1994, were diagnostic criteria defined at the Orlando conference, being adopted by the Committee for Classification of Chronic Pain of the International Association for the Study of Pain (IASP).[61],[64] These criteria were modified into a higher specificity version, the Budapest criteria, which included the motor features.[65] [Figure 4]. | Figure 4: Schematic representative overview of the original and updated IASP criteria for CRPS. For a complete review of criteria, the authors suggest further reading of the references provided in the text
Click here to view |
Even though CRPS diagnosis is performed by clinical criteria, mechanical testing, autonomic function evaluation and 3-phase bone scans can help confirm it. However, none of these exams has been determined as a prerequisite for diagnosis.[24],[66]
CRPS is divided into 2 types: type I (CRPS I), which occurs in the absence of a known or confirmed nerve injury, and type II (CRPS II), which occurs in the presence of an identifiable nerve lesion.[24],[54],[61],[64] Although these subtypes are well defined, there are some difficulties in categorizing CRPS after CTSS. Some authors define CRPS after CTSS as CRPS I,[43] considering that it is difficult to determine that an injury was caused intraoperatively, whereas others determine that it is actually CRPS II,[24],[54] accepting the fact that an iatrogenic lesion occurred intraoperatively. Although some progress in diagnosis has been reached, there still remain some issues about the authenticity of CRPS I, mainly because it presents many non-specific symptoms inconsistent with the causative event.[67],[68]
CRPS after CTSS: epidemiology, risks, and associated factors
The reported incidence of CRPS is 5-25 per 100.000 people/year,[69] Type I being the most common.[56],[69],[70] The exact epidemiology of CRPS after hand surgery is uncertain[70]; however, literature reports it as a complication of CTSS in 2-5% of patients.[8],[53],[58] There is a tendency to decrease the incidence over the first 3 postoperative months with stabilization of the prevalence after 6 months.[44]
Many authors describe that women are more affected than men,[43] probably due to the higher prevalence of CTS in females.[28],[44],[71] Diabetes Mellitus and hypertension are risk factors for CTS,[71] but not for CRPS post CTS; migraine also has no association.[28],[44]
Some authors claim that there is no difference between genders, age and body mass index (BMI),[28] while others suggest that age higher than 42 years and surgery of the dominant hand represent risk factors.[44] Also, there is the possibility of misleading diagnosis of CTS as CRPS in earlier stage.[43] Regarding the anesthetic techniques commonly used at the surgery for carpal tunnel release, there are no differences in the development of CRPS, although the duration of tourniquet can be a factor for the development of this complication in patients undergoing general anesthesia and brachial plexus block.[28]
Although the type of CTSS procedure (endoscopic x open) do not influence the rate of CRPS,[72] early surgery for moderate to severe cases have better outcome[59]; and the control of postoperative acute pain is extremely important to prevent the development of chronic pain.[73] Some papers recommend the use of perioperative gabapentin to reduce its incidence.[74] However, these data have not been supported in RCTs.[33] Some surgeons still apply some kind of splint after CTSS, although there are no evidences that orthoses following routine release of carpal tunnel can prevent CRPS.[31]
CRPS after CTSS management
Several treatment modalities were described for CRPS post CTSS. Management includes physiotherapy with or without associated medications and interventions,[25],[32],[35],[36],[39],[40],[49],[57] botulinum toxin,[56] stellate ganglion blockage,[8] peripheral nerve stimulation in median nerve,[54] axillary brachial plexus block with patient-controlled analgesia,[49] neurolysis and flap coverage of median nerve,[52] even amputation was disclosed in a report to treat CRPS complications[51] [Table 1 and 4]. Calcitonin, for a long time used as a treatment for CRPS, is no longer recommended.[75] Other modalities as intrathecal delivery of medications and spinal cord stimulation are options to CRPS treatment, but not specifically to treat CRPS after CTSS, and could be appraised in an earlier phase.[76]
Early diagnostic and treatment are extremely important in the management of CRPS.[8],[51] There are no evidences to determine how long conservative measures should be applied before the adoption of more invasive procedures. Most patients improve within one year,[70] while others remain with symptoms up to nine years.[77]
Patients treated for CRPS with good results are at risk of developing it again if required to undergo a surgery in the same region. This suggest the syndrome, regardless of treatment, can be recurrent or migratory, but this information is controversial and reported in few case on literature.[78] The reasons why this complication affects only some patients are not clear. However, an evaluation of the function of the sympathetic nervous system preoperatively can help to identify them. This evaluation can be performed with Laser Doppler Image.[38] Once identified, the patient can have a preemptive stellate ganglion block to lessen the regress of CRPS.[37] An alternative treatment for recurrent CTS associated with CRPS is a new release of the transverse carpal ligament combined with neurolysis of the median nerve, although this may be insufficient to ease the symptoms.[79] Preoperative gabapentin was used for many years to decrease pain intensity and the development of CRPS after CTSS. However, there are no evidences confirming its efficacy.[33] Myofascial pain syndrome (MFPS) is described in association with CRPS affecting proximal muscles, and evidences suggest that treatment of this condition may improve CRPS.[56]
For patients that show no improvement with any form of treatment and persist with severe symptoms, functional disability and incapacitant pain, amputation may represent the only option.[80]
CRPS after CTSS: other considerations
Some RCTs stress the importance of advising patients about CTSS risks, expressing their concern that many of the patients, despite receiving written information about complications following CTSS, did not remember that CRPS is a possible complication.[81]
The strength of this publication lies in the summary of the epidemiology and associate factors and risks. The main limitation is the impossibility to provide a high degree of treatment recommendation, considering the lack of systematic treatment procedures, biased publications and the overall low-quality assessment of the included papers.
» Conclusion | |  |
CRPS affects 2-5% of patients undergoing CTSS, configuring a dreaded complication involving functional and psychological disabilities. Its diagnosis still represents a challenge in clinical practice. Risk factors are unclear, although it seems to affect more women, from the fifty decades of life, in dominant hand. The most used treatments are physiotherapy and stellate ganglion blockage. Most patients show improvement of symptoms within one year. Further clinical trials, comparing treatment modalities, are required.
Acknowledgements
The Authors would like to thank Areta Ulhana Galat (Master of Arts in Teaching of English as a Second Language of Ilinois – Urbana – Champaign) for language editing.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
» References | |  |
1. | Padua L, Coraci D, Erra C, Pazzaglia C, Paolasso I, Loreti C, et al. Carpal tunnel syndrome: Clinical features, diagnosis, and management. Lancet Neurol 2016;15:1273-84. |
2. | Newington L, Harris EC. Carpal tunnel syndrome and work. Best Pract Res Clin Rheumatol 2015;29:440-53. |
3. | Atroshi I, Gummesson C, Johnsson R, Ornstein E, Ranstam J, Rosén I. Prevalence of carpal tunnel syndrome in a general population. JAMA 1999;282:153. |
4. | De Krom MC, Knipschild PG, Kester AD, Thijs CT, Boekkooi PF, Spaans F. Carpal tunnel syndrome: Prevalence in the general population. J Clin Epidemiol 1992;45:373-6. |
5. | Redzwan Habib K. Estimation of carpal tunnel syndrome (CTS) prevalence in adult population in Western European countries: A systematic review. Eur J Clin Biomed Sci 2017;3:13. |
6. | Jimenez DF, Gibbs SR, Clapper AT. Endoscopic treatment of carpal tunnel syndrome: A critical review. Neurosurg Focus 1997;3:e6. |
7. | Kuschner SH, Brien WW, Johnson D, Gellman H. Complications associated with carpal tunnel release. Orthop Rev 1991;20:346-52. |
8. | MacDonald RI, Lichtman DM, Hanlon JJ, Wilson JN. Complications of surgical release for carpal tunnel syndrome. J Hand Surg Am 1978;3:70-6. |
9. | |
10. | |
11. | |
12. | Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al. Grading quality of evidence and strength of recommendations. BMJ 2004;328:1490. |
13. | Slattery PG. Endoscopic carpal tunnel release. Use of the modified Chow technique in 215 cases. Med J Aust 1994;160:104-7. |
14. | Cho DS, Cho MJ. The electrodiagnosis of the carpal tunnel syndrome. S D J Med 1989;42:5-8. |
15. | Resnick CT, Miller BW. Endoscopic carpal tunnel release using the subligamentous two-portal technique. Contemp Orthop 1991;22:269-77. |
16. | NCT00904202. A Study Of Lidocaine Patch 5% Alone, Gabapentin Alone, And Lidocaine Patch 5% And Gabapentin In Combination For The Relief Of Pain In Patients With Diverse Peripheral Neuropathic Pain Conditions. Available from: https://clinicaltrials.gov/show/nct00904202. |
17. | Boeckstyns ME, Sørensen AI. Does endoscopic carpal tunnel release have a higher rate of complications than open carpal tunnel release? An analysis of published series. J Hand Surg Br 1999;24:9-15. |
18. | |
19. | Braun RM, Rechnic M, Fowler E. Complications related to carpal tunnel release. Hand Clin 2002;18:347-57. |
20. | Chen L, Duan X, Huang X, Lv J, Peng K, Xiang Z. Effectiveness and safety of endoscopic versus open carpal tunnel decompression. Arch Orthop Trauma Surg 2014;134:585-93. |
21. | Gay A-M, Béréni N, Legré R. Type I complex regional pain syndrome. Chir Main 2013;32:269-80. |
22. | Goh EL, Chidambaram S, Ma D. Complex regional pain syndrome: A recent update. Burn Trauma 2017;5:2. |
23. | |
24. | Li Z, Smith BP, Tuohy C, Smith TL, Andrew Koman L. Complex regional pain syndrome after hand surgery. Hand Clin 2010;26:281-9. |
25. | Smart KM, Wand BM, O'Connell NE. Physiotherapy for pain and disability in adults with complex regional pain syndrome (CRPS) types I and II. Cochrane Database Syst Rev 2016;2:CD010853. |
26. | |
27. | Brown RA, Gelberman RH, Seiler JG, Abrahamsson SO, Weiland AJ, Urbaniak JR, et al. Carpal tunnel release. A prospective, randomized assessment of open and endoscopic methods. J Bone Joint Surg Am 1993;75:1265-75. |
28. | |
29. | Dumontier C, Sokolow C, Leclercq C, Chauvin P. Early results of conventional versus two-portal endoscopic carpal tunnel release. J Hand Surg Am 1995;20:658-62. |
30. | Gerritsen AA, de Vet HC, Scholten RJ, Bertelsmann FW, de Krom MCTFM, Bouter LM. Splinting vs surgery in the treatment of carpal tunnel syndrome: A randomized controlled trial. JAMA 2002;288:1245-51. |
31. | Logli AL, Bear BJ, Schwartz EG, Korcek KJ, Foster BJ. A prospective, randomized trial of splinting after minicarpal tunnel release. J Hand Surg Am 2018;43:775.e1-8. |
32. | Malhotra R, Kiran EK, Dua A, Mallinath SG, Bhan S. Endoscopic versus open carpal tunnel release: A short-term comparative study. Indian J Orthop 2007;41:57-61.  [ PUBMED] [Full text] |
33. | Sadatsune EJ, Leal P da C, Cossetti RJ, Sakata RK. Effect of preoperative gabapentin on pain intensity and development of chronic pain after carpal tunnel syndrome surgical treatment in women: Randomized, double-blind, placebo-controlled study. Sao Paulo Med J 2016;134:285-91. |
34. | Sennwald GR, Benedetti R. The value of one-portal endoscopic carpal tunnel release: A prospective randomized study. Knee Surg Sports Traumatol Arthrosc 1995;3:113-6. |
35. | Trumble TE, Diao E, Abrams RA, Gilbert-Anderson MM. Single-portal endoscopic carpal tunnel release compared with open release: A prospective, randomized trial. J Bone Joint Surg Am 2002;84-A: 1107-15. |
36. | Zyluk A, Strychar J. A comparison of two limited open techniques for carpal tunnel release. J Hand Surg Am 2006;31:466-72. |
37. | Reuben SS, Rosenthal EA, Steinberg RB. Surgery on the affected upper extremity of patients with a history of complex regional pain syndrome: A retrospective study of 100 patients. J Hand Surg Am 2000;25:1147-51. |
38. | Ackerman WE, Ahmad M. Recurrent postoperative CRPS I in patients with abnormal preoperative sympathetic function. J Hand Surg Am 2008;33:217-22. |
39. | Davies BW, Pennington GA, Fritz AM. Two-portal endoscopic carpal tunnel release: An outcome analysis of 333 hands. Ann Plast Surg 1998;40:542-8. |
40. | Elmaraghy MW, Hurst LN. Single-portal endoscopic carpal tunnel release: Agee carpal tunnel release system. Ann Plast Surg 1996;36:286-91. |
41. | Lazaro RP, Eagan T. Concurrent musculoskeletal and soft tissue pain in the upper extremity can affect the treatment and prognosis of carpal tunnel syndrome: Redefining a common condition. J Pain Res 2017;10:2497-502. |
42. | Loewenstein SN, Duquette SP, Adkinson JM. Combined carpal tunnel release and palmar fasciectomy for Dupuytren's contracture does not increase the risk for complex regional pain syndrome. Plast Reconstr Surg 2018;142:1251-7. |
43. | Petersen PB, Mikkelsen KL, Lauritzen JB, Krogsgaard MR. Risk factors for post-treatment complex regional pain syndrome (CRPS): An analysis of 647 cases of crps from the Danish Patient Compensation Association. Pain Pract 2018;18:341-9. |
44. | Shariatzadeh H, Mujeb Mohseni M. Incidence of Complex regional pain syndrome following the carpal tunnel release surgery. Shafa Orthop J 2017;4. |
45. | Tuzuner S, Sherman GM, Ozkaynak S, Ozcanli H. Endoscopic carpal tunnel release: Modification of Menon's technique and data from 191 cases. Arthroscopy 2004;20:721-7. |
46. | Brown MG, Keyser B, Rothenberg ES. Endoscopic carpal tunnel release. J Hand Surg Am 1992;17:1009-11. |
47. | Turgut M, Bölükbaşi O, Akyol A. Chemical sympathectomy in the relief of persistent sympathetic pain after carpal tunnel release. A case report. J Neurosurg Sci 1999;43:191-3; discussion 194. |
48. | Waegeneers S, Haentjens P, Wylock P. Operative treatment of carpal tunnel syndrome. Acta Orthop Belg 1993;59:367-70. |
49. | Wang L. Axillary brachial plexus block with patient controlled analgesia for complex regional pain syndrome type I: A case report. Reg Anesth Pain Med 2001;26:68-71. |
50. | Lilly SI, Stern PJ. Simultaneous carpal tunnel release and Dupuytren's fasciectomy. J Hand Surg Am 2010;35:754-9. |
51. | Carpenter D, Draeger R. Neurogenic edema from complex regional pain syndrome resulting in fulminant infection necessitating below elbow amputation. J Hand Microsurg 2017;09:159-62. |
52. | Cheung K, Klausmeyer MA, Jupiter JB. Abductor digiti minimi flap for vascularized coverage in the surgical management of complex regional pain syndrome following carpal tunnel release. Hand (N Y) 2017;12:546-50. |
53. | Lichtman DM, Florio RL, Mack GR. Carpal tunnel release under local anesthesia: Evaluation of the outpatient procedure. J Hand Surg Am 1979;4:544-6. |
54. | Mirone G, Natale M, Rotondo M. Peripheral median nerve stimulation for the treatment of iatrogenic complex regional pain syndrome (CRPS) type II after carpal tunnel surgery. J Clin Neurosci 2009;16:825-7. |
55. | Rahman KU, Rahman S, Khan A, Khan NA, Khan FU, Khan RA, et al. Assessing the complications and effectiveness of open carpal tunnel release in a tertiary care centre in a developing country. Int J Surg Case Rep 2014;5:209-11. |
56. | Safarpour D, Jabbari B. Botulinum toxin A (Botox) for treatment of proximal myofascial pain in complex regional pain syndrome: Two cases. Pain Med 2010;11:1415-8. |
57. | Schonauer F, Varma S, Belcher HJ. Endoscopic carpal tunnel release: Practice in evolution. Scand J Plast Reconstr Surg Hand Surg 2003;37:360-4. |
58. | Shinya K, Lanzetta M, Conolly WB. Risk and complications in endoscopic carpal tunnel release. J Hand Surg Br 1995;20:222-7. |
59. | Chandra PS, Singh PK, Goyal V, Chauhan AK, Thakkur N, Tripathi M. Early versus delayed endoscopic surgery for carpal tunnel syndrome: Prospective randomized study. World Neurosurg 2013;79:767-72. |
60. | Ram S. “Carpal tunnel syndrome:” A bibliometric study of 35 years of research. Neurol India 2019;67:55-61.  [ PUBMED] [Full text] |
61. | Harden RN, Oaklander AL, Burton AW, Perez RS, Richardson K, Swan M, et al. Complex regional pain syndrome: Practical diagnostic and treatment guidelines, 4 th edition. Pain Med 2013;14:180-229. |
62. | Zimmerman RM, Astifidis RP, Katz RD. Modalities for complex regional pain syndrome. J Hand Surg Am 2015;40:1469-72. |
63. | Weiskopf RB, Raja SN, Grabow TS. CLINICAL CONCEPTS AND COMMENTARY Complex Regional Pain Syndrome I (Reflex Sympathetic Dystrophy). Anesthesiology 2002; 96:1254–6064. |
64. | Merskey H, Bogduk N, editors. Classification of Chronic Pain. 2 nd ed. Seattle: IASP Press; 1994. |
65. | Harden RN, Bruehl S, Perez RS, Birklein F, Marinus J, Maihofner C, et al. Validation of proposed diagnostic criteria (the Budapest Criteria) for complex regional pain syndrome. Pain 2010;150:268-74. |
66. | Lee GW, Weeks PM. The role of bone scintigraphy in diagnosing reflex sympathetic dystrophy. J Hand Surg Am 1995;20:458-63. |
67. | Borchers AT, Gershwin ME. The clinical relevance of complex regional pain syndrome type I: The Emperor's New Clothes. Autoimmun Rev 2017;16:22-33. |
68. | del Piñal F. Editorial: I have a dream … reflex sympathetic dystrophy (RSD or complex regional pain syndrome-CRPS I) does not exist. J Hand Surg Eur Vol 2013;38:595-7. |
69. | Yun SC, Mi GL, Hyo ML, Chul JL, Ji YJ, Soo YJ, et al. Epidemiology of complex regional pain syndrome: A retrospective chart review of 150 Korean patients. J Korean Med Sci 2008;23:772-5. |
70. | Sandroni P, Benrud-Larson LM, McClelland RL, Low PA. Complex regional pain syndrome type I: Incidence and prevalence in Olmsted county, a population-based study. Pain 2003;103:199-207. |
71. | Sharief F, Kanmani J, Kumar S. Risk factors, symptom severity and functional status among patients with carpel tunnel syndrome. Neurol India 2018;66:743-6.  [ PUBMED] [Full text] |
72. | Mertz K, Trunzter J, Wu E, Barnes J, Eppler SL, Kamal RN. National trends in the diagnosis of crps after open and endoscopic carpal tunnel release. J Wrist Surg 2019;8:209-14. |
73. | Poleshuck EL, Katz J, Andrus CH, Hogan LA, Jung BF, Kulick DI, et al. Risk factors for chronic pain following breast cancer surgery: A prospective study. J Pain 2006;7:626-34. |
74. | Clarke H, Bonin RP, Orser BA, Englesakis M, Wijeysundera DN, Katz J. The prevention of chronic postsurgical pain using gabapentin and pregabalin. Anesth Analg 2012;115:428-42. |
75. | Sahin F, Yilmaz F, Kotevoglu N, Kuran B. Efficacy of salmon calcitonin in complex regional pain syndrome (type 1) in addition to physical therapy. Clin Rheumatol 2006;25:143-8. |
76. | Poree L, Krames E, Pope J, Deer TR, Levy R, Schultz L. Spinal cord stimulation as treatment for complex regional pain syndrome should be considered earlier than last resort therapy. Neuromodulation 2013;16:125-41. |
77. | Geertzen JH, Dijkstra PU, van Sonderen EL, Groothoff JW, ten Duis HJ, Eisma WH. Relationship between impairments, disability and handicap in reflex sympathetic dystrophy patients: A long-term follow-up study. Clin Rehabil 1998;12:402-12. |
78. | Akkus S, Yorgancigil H, Yener M. A case of recurrent and migratory complex regional pain syndrome type I: Prevention by gabapentin. Rheumatol Int 2006;26:852-4. |
79. | Jones NF, Ahn HC, Eo S. Revision surgery for persistent and recurrent carpal tunnel syndrome and for failed carpal tunnel release. Plast Reconstr Surg 2012;129:683-92. |
80. | Krans-Schreuder HK, Bodde MI, Schrier E, Dijkstra PU, van den Dungen JA, den Dunnen WF, et al. Amputation for long-standing, therapy-resistant type-I complex regional pain syndrome. J Bone Joint Surg Am 2012;94:2263-8. |
81. | Wong AL, Martin J, Tang D, LeBlanc M, Morris SF, Paletz J, et al. The effect of written information on recall of surgical risks of carpal tunnel release surgery. Plast Reconstr Surg 2016;138:1011e-8e. |
[Figure 1], [Figure 2], [Figure 3], [Figure 4]
[Table 1], [Table 2], [Table 3], [Table 4]
|